Related Experiment Video

Updated: May 11, 2026

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on: March 29, 2024

MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines

A Vultur1, J Villanueva1, C Krepler1

  • 1Molecular and Cellular Oncogenesis Program, Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA.

Oncogene
|April 30, 2013
PubMed

Insights

Mitogen-activated protein kinase (MAPK) pathway inhibitors can unexpectedly increase melanoma cell invasion by activating STAT3 signaling. Combined targeting of MAPK and STAT3 may overcome treatment resistance and reduce melanoma spread.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Mitogen-activated protein kinase (MAPK) signaling is crucial for melanoma progression.
  • Targeted therapies inhibiting MAPK pathways are standard, but melanoma's heterogeneity poses challenges.
  • The impact of these therapies on tumor biology, particularly invasion, requires further investigation.

Purpose of the Study:

  • To investigate how MEK and BRAF inhibitors affect melanoma cell invasion.
  • To identify the signaling pathways involved in therapy-induced invasion.
  • To explore combination strategies to overcome resistance and prevent invasion.

Main Methods:

  • Utilized a 3D collagen-embedded spheroid melanoma model.
  • Assessed the effects of MEK and BRAF inhibitors on melanoma cell lines.
  • Analyzed receptor tyrosine kinase (RTK), Src/FAK/STAT3 signaling, and cell adhesion.
  • Tested combination therapies targeting MAPK, RTKs, Src, FAK, and STAT3.

Main Results:

  • MEK and BRAF inhibitors increased invasion in ~20% of melanoma cell lines.
  • Invasive cells showed elevated RTK activity and Src/FAK/STAT3 pathway activation.
  • STAT3 signaling was induced in BRAF-inhibitor-resistant cells.
  • Combined inhibition of MAPK with RTKs, Src, FAK, or STAT3 prevented invasion; only STAT3 inhibition induced cell death.

Conclusions:

  • MEK and BRAF inhibitors can paradoxically enhance melanoma invasion via STAT3 activation.
  • STAT3 signaling plays a key role in MAPK inhibitor resistance.
  • Combined targeting of MAPK and STAT3 pathways offers a promising strategy against invasive melanoma and treatment resistance.

More Related Videos

Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy09:17

Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy

Published on: September 16, 2019

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...